Avishay Edri

Avishay Edri is a Senior Project Manager at Gamida Cell Ltd. since April 2021, leading the GDA601 program focused on genetically modified NK cell immunotherapy for multiple myeloma, and also working on the GDA-201 program targeting hematologic and solid tumors. Previously, Avishay served as an Industrial Postdoctoral Researcher at Poold Diagnostics L.T.D., where research concentrated on enhancing COVID-19 testing capacity through a novel combinatorial pooling method. Avishay's academic background includes a Ph.D. in Immunology and extensive teaching assistant roles in various courses at Ben-Gurion University of the Negev. The educational journey also includes a Master's in Virology and a Bachelor's in Molecular Biology from the same institution.